| |
| |
|
| Insider
Information: |
Catinazzo Thomas |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
339,803 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,161,147 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
339,803 |
|
|
| Total
Value |
$2,161,147 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
339,803 |
2021-03-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-04-29 |
4 |
S |
$6.38 |
$10,814 |
D/D |
(1,695) |
339,803 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-03-27 |
4 |
S |
$7.70 |
$2,680 |
D/D |
(348) |
341,498 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-01-29 |
4 |
S |
$9.64 |
$19,328 |
D/D |
(2,005) |
341,846 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
343,851 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-12-27 |
4 |
S |
$11.51 |
$3,384 |
D/D |
(294) |
143,851 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-10-30 |
4 |
S |
$6.03 |
$10,233 |
D/D |
(1,697) |
144,145 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-09-27 |
4 |
S |
$8.38 |
$2,464 |
D/D |
(294) |
145,842 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-07-28 |
4 |
S |
$11.80 |
$19,977 |
D/D |
(1,693) |
146,136 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-27 |
4 |
S |
$12.12 |
$3,563 |
D/D |
(294) |
147,829 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-04-28 |
4 |
S |
$11.16 |
$9,631 |
D/D |
(863) |
149,272 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-04-28 |
4/A |
S |
$11.16 |
$22,454 |
D/D |
(2,012) |
148,123 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-03-27 |
4 |
S |
$15.36 |
$5,330 |
D/D |
(347) |
150,135 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-01-30 |
4 |
S |
$21.56 |
$18,628 |
D/D |
(864) |
150,482 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
101,115 |
151,346 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-27 |
4 |
S |
$14.49 |
$6,448 |
D/D |
(445) |
50,231 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-10-28 |
4 |
S |
$21.54 |
$23,672 |
D/D |
(1,099) |
50,676 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-09-27 |
4 |
S |
$22.73 |
$10,069 |
D/D |
(443) |
51,775 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-09-08 |
4 |
AS |
$30.00 |
$787,710 |
D/D |
(26,257) |
52,218 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-09-08 |
4 |
OE |
$4.12 |
$108,179 |
D/D |
26,257 |
78,475 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-07-28 |
4 |
S |
$21.26 |
$15,605 |
D/D |
(734) |
52,218 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-06-27 |
4 |
S |
$20.31 |
$6,093 |
D/D |
(300) |
52,952 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-28 |
4 |
S |
$25.57 |
$18,538 |
D/D |
(725) |
53,252 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-03-29 |
4 |
S |
$29.87 |
$8,423 |
D/D |
(282) |
53,977 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-03-24 |
4 |
OE |
$4.12 |
$54,738 |
D/D |
13,286 |
67,545 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-03-24 |
4 |
AS |
$30.00 |
$398,580 |
D/D |
(13,286) |
54,259 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
